Skip to main content
Clinical Trials/NCT05912660
NCT05912660
Completed
Not Applicable

Health Status of Patients After Surgically Implanted Biological and TAVI: a Population-based Retrospective Analysis

Medical University of Vienna0 sites18,882 target enrollmentJanuary 1, 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Aortic Valve Disease
Sponsor
Medical University of Vienna
Enrollment
18882
Primary Endpoint
all-cause mortality
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The overall project aim is to study outcomes following aortic valve replacement with surgically implanted bioprostheses or TAVI by retrieving data from the main social security carriers in Austria for the years 2010-2020.

Registry
clinicaltrials.gov
Start Date
January 1, 2010
End Date
December 31, 2020
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hendrik Jan Ankersmit

Univ. Prof. , MD, MBA

Medical University of Vienna

Eligibility Criteria

Inclusion Criteria

  • isolated aortic valve replacement in Austria (surgically implanted bioprostheses or TAVI)

Exclusion Criteria

  • below 65 years of age
  • coronary revascularization within 4 months before the index procedure
  • concomitant heart surgery

Outcomes

Primary Outcomes

all-cause mortality

Time Frame: 10 years

all cause mortality after aortic valve replacement

Secondary Outcomes

  • stroke(10 years)
  • heart failure(10 years)
  • myocardial infaction(10 years)
  • reoperation(10 years)

Similar Trials